ATE303136T1 - Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung - Google Patents

Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung

Info

Publication number: ATE303136T1
Authority: AT; Austria
Prior art keywords: anhydrous; ranitidine hydrochloride; composition; tablet containing; coated tablet
Prior art date: 1999-04-12

Application number

AT00925209T

Other languages

English (en)

Inventor

Paolo Alberto Veronesi

Emanuela Peschechera

Dotti Xavier Cirera

Original Assignee

Pharmexcel Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-12

Filing date

2000-04-11

Publication date

2005-09-15

2000-04-11 Application filed by Pharmexcel Srl filed Critical Pharmexcel Srl

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE303136T1 publication Critical patent/ATE303136T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
229960001520 ranitidine hydrochloride Drugs 0.000 title abstract 3
GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 title abstract 3
239000004480 active ingredient Substances 0.000 abstract 2
239000011248 coating agent Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT00925209T 1999-04-12 2000-04-11 Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung ATE303136T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT1999MI000740A IT1311915B1 (it)	1999-04-12	1999-04-12	Compressa anidra di cloridrato di ranitidina con rivestimento a doppiostrato e sua composizione.
PCT/EP2000/003330 WO2000061118A1 (en)	1999-04-12	2000-04-11	Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition

Publications (1)

Publication Number	Publication Date
ATE303136T1 true ATE303136T1 (de)	2005-09-15

Family

ID=11382663

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00925209T ATE303136T1 (de)	1999-04-12	2000-04-11	Wasserfreie ranitidinhydrochlorid enthaltende tablette mit zweischichtigem überzug und deren zusammensetzung

Country Status (6)

Country	Link
EP (1)	EP1171102B1 (de)
AT (1)	ATE303136T1 (de)
AU (1)	AU4400500A (de)
DE (1)	DE60022334D1 (de)
IT (1)	IT1311915B1 (de)
WO (1)	WO2000061118A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BG65305B1 (bg) *	2001-06-05	2008-01-31	"Унифарм" Ад	Лекарствена форма, съдържаща ранитидин
CN105030694A (zh) *	2015-08-04	2015-11-11	青岛蓝盛洋医药生物科技有限责任公司	一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN115944601A (zh) *	2023-02-17	2023-04-11	山西太原药业有限公司	一种有效控制n-亚硝基二甲胺（ndma）生成的盐酸雷尼替丁胶囊制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK171127B1 (da) *	1994-04-22	1996-06-24	Gea Farmaceutisk Fabrik As	Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
DE69504156T2 (de) *	1994-06-24	1998-12-24	Ranbaxy Laboratories, Ltd., New Delhi	Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
US5853756A (en) *	1995-01-11	1998-12-29	J. B. Chemicals & Pharmaceuticals Limited	Controlled release formulations of Ranitidine
DE19511131A1 (de) *	1995-03-27	1996-10-02	Basf Ag	Mechanisch stabile feste Wirkstoffzubereitungsformen

1999
- 1999-04-12 IT IT1999MI000740A patent/IT1311915B1/it active
2000
- 2000-04-11 WO PCT/EP2000/003330 patent/WO2000061118A1/en not_active Ceased
- 2000-04-11 AT AT00925209T patent/ATE303136T1/de not_active IP Right Cessation
- 2000-04-11 EP EP00925209A patent/EP1171102B1/de not_active Expired - Lifetime
- 2000-04-11 AU AU44005/00A patent/AU4400500A/en not_active Abandoned
- 2000-04-11 DE DE60022334T patent/DE60022334D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1171102A1 (de)	2002-01-16
WO2000061118A1 (en)	2000-10-19
EP1171102B1 (de)	2005-08-31
IT1311915B1 (it)	2002-03-20
ITMI990740A1 (it)	2000-10-12
DE60022334D1 (de)	2005-10-06
AU4400500A (en)	2000-11-14

Similar Documents

Publication	Publication Date	Title
EA200400471A1 (ru)	2004-10-28	Оральная дозированная форма пропиверина
CA2339991A1 (en)	2000-02-24	Microemulsions as solid dosage forms for oral administration
CA2316485A1 (en)	1999-07-08	Sustained-release pharmaceutical composition
RU94041836A (ru)	1997-02-20	Производные амидина, смесь их изомеров или отдельные изомеры и их соли, фармацевтическая композиция с антагонистической в отношении лейкотриена в*004 активностью
CA2251886A1 (en)	1997-10-30	An oral pharmaceutical formulation containing ibandronate
CA2326517A1 (en)	1999-10-07	New galenic preparations of meloxicam for oral administration
EP1619180A4 (de)	2006-05-24	Casr-antagonist
ATE158504T1 (de)	1997-10-15	Brausemischungen enthaltend ibuprofen und verfahren
NO20005162D0 (no)	2000-10-13	Forbindelser som inhiberer bindingen av integriner til deres reseptorer
CA2445519A1 (en)	2002-11-07	Method for manufacturing a low dose pharmaceutical composition
CA2361402A1 (en)	2001-03-15	Bis-sulfonamides
WO2002030467A3 (en)	2002-10-24	Pharmaceutical composition containing honey for the treatment of wounds
SE0102440D0 (sv)	2001-07-05	New compound
ID22763A (id)	1999-12-09	Komposisi penstabil tibolon
PL337279A1 (en)	2000-08-14	Pharmaceutical with controlled releose containing inhibitor ace as an active substance
KR890006236A (ko)	1989-06-12	피페리디노 알칸올-충혈제거제 조합을 위한 약제학적 조성물
AU4400500A (en)	2000-11-14	Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition
BE2016C017I2 (de)	2021-07-19
GEP20043377B (en)	2004-04-13	Pharmaceutical Complex
NO20013601L (no)	2001-09-11	Nye morfolinobenzamidsalter
MXPA02006250A (es)	2004-09-06	Derivados de butino diol.
MY101266A (en)	1991-08-17	Pharmaceutical formulations
NZ505080A (en)	2002-09-27	Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
ATE258046T1 (de)	2004-02-15	Pharmazeutische, metamizol enthaltende brauseformulierung
HUP9802437A3 (en)	1999-03-29	5-pyrazolylbenzoic acid derivatives, herbicidal, desiccant and defoliant compositions containing these compounds as active ingredients, preparation and use of the latest

Legal Events

Date	Code	Title	Description
2006-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties